KAT6B and mesenchymal cell neoplasm: The major novel finding of our study is that KAT6B/A::KANSL1 uterine tumours are defined by a specific DNA methylation signature that is distinct from other uterine mesenchymal neoplasms, indicating they constitute a distinct type of uterine mesenchymal tumour.